IL13 and metabolic dysfunction-associated steatohepatitis: Since Th2 expresses high levels of IL13, and its proportion was found to increase in the liver and blood of NASH patients, this finding suggests that Th2-derived IL13 may promote NASH progression by interacting with IL-13Rα2-positive hepatic stellate cells [62].